quantisnow
FeedTopReportsPricing
⌘K
Live feed
11:45:06·1016d
NEWSRelease
Aurora Cannabis Inc. logo
Akanda Corp. logo
Canopy Growth Corporation logo
+14

'Bipartisan Lawmakers Push For Marijuana And Psychedelics Amendments To Defense Bill, But Committee Action Is Delayed' - Marijuana Moment

ACB· Aurora Cannabis Inc.AKAN· Akanda Corp.CGC· Canopy Growth CorporationCMPS· COMPASS Pathways PlcCRON· Cronos Group Inc.CYBN· Cybin Inc.
Health CareConsumer DiscretionaryTechnology
Original source

Companies

  • ACB
    Aurora Cannabis Inc.
    Health Care
  • AKAN
    Akanda Corp.
    Health Care
  • CGC
    Canopy Growth Corporation
    Health Care
  • CMPS
    COMPASS Pathways Plc
    Health Care
  • CRON
    Cronos Group Inc.
    Health Care
  • CYBN
    Cybin Inc.
    Health Care
  • DRUG
    Bright Minds Biosciences Inc.
    Health Care
  • ENVB
    Enveric Biosciences Inc.
    Health Care
  • GRWG
    GrowGeneration Corp.
    Consumer Discretionary
  • IGC
    IGC Pharma Inc.
    Health Care
  • IMCC
    IM Cannabis Corp.
    Health Care
  • KERN
    Akerna Corp.
    Technology
  • LFLY
    Leafly Holdings Inc.
    Technology
  • MNMD
    Mind Medicine (MindMed) Inc.
    Health Care
  • REUN
    Reunion Neuroscience Inc.
    Health Care
  • SNDL
    SNDL Inc.
    Health Care
  • TLRY
    Tilray Brands Inc.
    Health Care

Recent analyst ratings

  • Apr 13DRUGUpdateJefferies$145.00
  • Apr 3TLRYUpdateRoth Capital$10.00
  • Apr 2TLRYUpdateRoth Capital$10.00
  • Mar 27CGCUpdateCanaccord Genuity-
  • Jan 27TLRYUpdateCanaccord Genuity-
  • Jan 27ACBUpdateCanaccord Genuity-

Related

  • SEC15h
    SEC Form S-3 filed by Enveric Biosciences Inc.
  • PR22h
    Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
  • PR1d
    'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
  • PR1d
    BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
  • INSIDER1d
    SEC Form 4 filed by Hopkinson David G.
  • NEWS1d
    IGC Pharma Adds Kerwin Medical Center in Dallas to Phase 2 CALMA Trial as Enrollment Advances Toward Completion
  • SEC2d
    Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC2d
    SEC Form 424B7 filed by Tilray Brands Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022